The Ldn Book Av Linda Elsegood

<p><strong>Could a little-known drug really revolutionize treatment for autoimmune diseases, cancer, depression, and more?</strong></p><p><strong>¿</strong><strong>[LDN] raises hopes of reversing memory loss in old age.¿¿<em>the Guardian</em></strong></p><p><strong>Over 30,000 copies sold!</strong></p><p>Low Dose Naltrexone (LDN) holds the potential to help millions of people suffering from various autoimmune diseases and cancers, and even autism, chronic fatigue, and depression, find relief. Administered off-label in small daily doses (0.5 to 4.5 mg), this generic drug is extremely affordable and presents few known side effects.</p><p><strong>So why has it languished in relative medical obscurity?</strong><br/><br/><em>The LDN Book</em> explains:</p><ul><li>The drug¿s origins</li><li>Its primary mechanism</li><li>The latest research from practicing physicians and pharmacists</li></ul><p> </p><p>Compiled by Linda Elsegood of The LDN Research Trust¿the world¿s largest LDN charity orga